vimarsana.com
Home
Live Updates
Arbutus Presents New Data on AB-729, AB-836 and AB-101 at : comparemela.com
Arbutus Presents New Data on AB-729, AB-836 and AB-101 at
AB-729, our RNAi therapeutic, provided robust and comparable HBsAg declines in both HBeAg+ and HBeAg- patients...
Related Keywords
William Collier ,
Fung Yuen ,
Arbutus Biopharma Corporation Nasdaq ,
Division Of Gastroenterology ,
Deputy Head Of Department ,
University Of Hong Kong ,
International Liver Congress ,
Webcast Scheduled ,
Biopharma Corporation ,
European Association ,
Chief Executive Officer ,
Data Poster ,
Man Fung Yuen ,
Deputy Head ,
Lap Chee ,
Hong Kong ,
Nasdaq Abus ,
Arbutus Biopharma Corporation ,
Arbutus ,
Arbutus Biopharma ,
Asl 2022 ,
Hronic Hbv ,
Gbv ,
Asl Poster Presentations ,
Asl Ilc 2022 ,
comparemela.com © 2020. All Rights Reserved.